Skip to main content
. Author manuscript; available in PMC: 2021 Dec 8.
Published in final edited form as: Pteridines. 2021 Sep 23;32(1):48–69. doi: 10.1515/pteridines-2020-0028

Table 4.

Inpatient psychiatric hospitalization in individuals with schizophrenia and bipolar disorder; comparison between lipophilic, hydrophilic and no statin groups.

Label Relative Risk Mean L’Beta Estimate Standard Error Alpha L’Beta Chi-Square P
Confidence Limit Confidence Limit
Lipophilic vs Hydrophilic Schizophrenia with anti-psychotic 1.11 1.0007 1.23 0.1 0.05 0.05 0.0007 0.21 3.89 0.048
BD with antipsychotic 1.22 1.09 1.36 0.2 0.06 0.05 0.08 0.31 11.42 <.001
BD with mood-stabilizer 1.18 1.06 1.32 0.17 0.05 0.05 0.06 0.27 9.37 0.002
Lipophilic vs None Schizophrenia with antipsychotic 0.81 0.77 0.86 −0.21 0.03 0.05 −0.26 −0.16 59.84 <.001
BD with antipsychotic 0.85 0.80 0.89 −0.17 0.03 0.05 −0.22 −0.11 36.88 <.001
BD with mood-stabilizer 0.83 0.79 0.88 −0.18 0.03 0.05 −0.23 −0.13 49.31 <.001
Hydrophilic vs None Schizophrenia with antipsychotic 0.73 0.67 0.80 −0.31 0.05 0.05 −0.40 −0.22 47.16 <.001
BD with antipsychotic 0.70 0.63 0.77 −0.36 0.05 0.05 −0.46 −0.26 50.07 <.001
BD with mood-stabilizer 0.70 0.64 0.77 −0.35 0.05 0.05 −0.44 −0.26 53.89 <.001

BD: Bipolar Disorder